Cargando…

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers

OBJECTIVE: To evaluate the success of initiation of adjunctive brivaracetam in patients who required a change in antiepileptic drug (AED) regimen and substituted at least one AED with brivaracetam. METHODS: In this retrospective noninterventional study conducted in specialized epilepsy centers acros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerche, Holger, Knake, Susanne, Rosenow, Felix, Schulze‐Bonhage, Andreas, Hellot, Scarlett, Leunikava, Iryna, Schulz, Anne‐Liv, Hopp, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469785/ https://www.ncbi.nlm.nih.gov/pubmed/32913953 http://dx.doi.org/10.1002/epi4.12415

Ejemplares similares

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
por: Rudà, Roberta, et al.
Publicado: (2020)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review
por: Depondt, Chantal, et al.
Publicado: (2021)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2019)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam
por: Ciceri, Samuele, et al.
Publicado: (2018)

A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy
por: Hirsch, Martin, et al.
Publicado: (2023)

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
por: Bast, Thomas, et al.
Publicado: (2022)

Impfung zur Vorbeugung der COVID-19-Erkrankung sowie Impfpriorisierung bei Epilepsie
por: Strzelczyk, Adam, et al.
Publicado: (2021)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
por: Reinhardt, Fritjof, et al.
Publicado: (2019)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Behavioral disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study
por: van Tuijl, Diana C., et al.
Publicado: (2017)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017)

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
por: Stefanatou, Maria, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial
por: Farkas, Mark Kristof, et al.
Publicado: (2022)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
por: Liu, Edwin, et al.
Publicado: (2019)

Brivaracetam in treating epileptic encephalopathy and refractory focal epilepsies in patients under 14 years of age
por: RUSSO, Angelo, et al.
Publicado: (2021)

Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs
por: Thieffry, Solène, et al.
Publicado: (2020)

Systematic review of antiepileptic drugs’ safety and effectiveness in feline epilepsy
por: Charalambous, Marios, et al.
Publicado: (2018)

How to identify insular epilepsy
por: Schulze-Bonhage, Andreas, et al.
Publicado: (2022)

Antiepileptic Drug Treatment in Children with Epilepsy
por: Rosati, Anna, et al.
Publicado: (2015)

Antiepileptic Drug Withdrawal in Dogs with Epilepsy
por: Gesell, Felix Kaspar, et al.
Publicado: (2015)

Discontinuation of antiepileptic drugs in adults with epilepsy
por: Laue-Gizzi, Hanka
Publicado: (2021)

Association of Anemia With Epilepsy and Antiepileptic Drugs
por: Padda, Jaskamal, et al.
Publicado: (2021)

Genetic Background of Epilepsy and Antiepileptic Treatments
por: Borowicz-Reutt, Kinga, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5st1p2bu69t8ngmi3ilvp8s2p0